Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biogen Inc BIIB

Healthcare Biotechnology
Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology... see more

Bullboard (NDAQ:BIIB)

View:
Post by MikeTesteron Aug 02, 2024 4:51pm

Biogen (NASDAQ:BIIB) – A Diversified Powerhouse Naviga

https://beyondspx.com/2024/07/31/biogen-nasdaqbiib-a-diversified-powerhouse-navigating-the-evolving-pharmaceutical-landscape/
37
Post by edwardebreen15on Aug 09, 2022 1:35am

Lignans Market Trends, Demand, Share and Reports 2021-2026

According to IMARC Group’s latest report, titled “Lignans Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global market grew at a CAGR of around 5% during ...more  
224
Comment by Joe455on May 29, 2022 12:04pm

RE:Biogen Sees Two Long-Time Directors Announce Retirement

A little fresh blood in management is good.
125
Discussion
Post by AwareInvestoron Jan 31, 2022 8:39am

Biogen Sees Two Long-Time Directors Announce Retirement

Biogen Inc appears to be facing issues related to its executive team. The firm this morning indicated that two long time directors of the company will be retiring from their positions. The retirements ...more  
227
Discussion
Post by TinTorontoon Jun 12, 2021 11:51pm

Outrageous that this was ever approved.

They fail to mention the brain lesions, edema, and bleeding that this drug causes.  They fail to mention that the average AD patient will be able to afford ongoing treatment of this drug due to ...more  
327
Post by AviseAnalyticson Jun 09, 2021 8:47am

$BIIB THE PATH AHEAD ISN’T EASY!

BIOGEN SCORES A BIG WIN FOR ADUHELM™, BUT THE PATH AHEAD ISN’T EASY!
212
Post by PowerOfTheSunon May 11, 2021 1:28pm

Just check great potential biotech company!

https://www.youtube.com/watch?v=Q2u-i1_pUAM&t=2s Long Term Great Potential Biotech Company! Stem Cell!
228
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities